Anti-CDK4/6 Boosts PFS in Metastatic Breast Cancer

(MedPage Today) -- 'Game changer' for HR-positive, HER2-negative disease
via Anti-CDK4/6 Boosts PFS in Metastatic Breast Cancer
by